hydroxyurea has been researched along with Injury, Ischemia-Reperfusion in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The participation of nitric oxide (NO) in oxidative reactions causes a reduction in NO bioavailability and contributes to vascular dysfunction in SCD." | 2.44 | Redox-dependent impairment of vascular function in sickle cell disease. ( Aslan, M; Freeman, BA, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, F | 1 |
| Soni, H | 1 |
| Pressly, JD | 1 |
| Adebiyi, A | 1 |
| Connes, P | 1 |
| Machado, R | 1 |
| Hue, O | 1 |
| Reid, H | 1 |
| Patel, NS | 1 |
| Cuzzocrea, S | 1 |
| Chatterjee, PK | 1 |
| Di Paola, R | 1 |
| Sautebin, L | 1 |
| Britti, D | 1 |
| Thiemermann, C | 1 |
| Aslan, M | 1 |
| Freeman, BA | 1 |
| Mangino, MJ | 1 |
| Murphy, MK | 1 |
| Anderson, CB | 1 |
| Su, M | 1 |
| Chi, EY | 1 |
| Bishop, MJ | 1 |
| Henderson, WR | 1 |
| Dolan, R | 1 |
| Hartshorn, K | 1 |
| Andry, C | 1 |
| Tablante, J | 1 |
| Grillone, G | 1 |
| McAvoy, D | 1 |
| Suntra, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aerobic Physical Fitness and Health-related Quality of Life in Children With Sickle Cell Disease.[NCT05995743] | 72 participants (Actual) | Observational | 2021-11-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydroxyurea and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
Topics: Adaptation, Physiological; Anemia, Sickle Cell; Arterial Occlusive Diseases; Bronchial Hyperreactivi | 2011 |
Redox-dependent impairment of vascular function in sickle cell disease.
Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents; Anticoagulants; Antioxidants; Biological Availability | 2007 |
5 other studies available for hydroxyurea and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Acute hydroxyurea treatment reduces tubular damage following bilateral ischemia-reperfusion injury in a mouse model of sickle cell disease.
Topics: Acute Kidney Injury; Anemia, Sickle Cell; Animals; Antisickling Agents; Biomarkers; Creatinine; Dise | 2019 |
Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.
Topics: Animals; Arachidonate 5-Lipoxygenase; Disease Models, Animal; Hydroxyurea; Inflammation; Intercellul | 2004 |
Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
Topics: Animals; Arachidonate 5-Lipoxygenase; Dogs; Hydroxyurea; Intestinal Mucosa; Intestines; Leukotriene | 1994 |
Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs.
Topics: Animals; Arterial Occlusive Diseases; Bronchoalveolar Lavage Fluid; Cell Count; Cell Degranulation; | 1993 |
In vivo correlation of neutrophil receptor expression, ischemia-reperfusion injury, and selective 5-lipoxygenase inhibition in guinea pigs.
Topics: Animals; CD18 Antigens; Female; Guinea Pigs; Hydroxyurea; Lipoxygenase Inhibitors; Neutrophil Activa | 1998 |